Skip to content

Zymeworks ZYME Convertible Preferred Stock Authorized Shares

Convertible Preferred Stock Authorized Shares at other companies

Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
10M0.0%
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
5M0.0%
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
5M0.0%
iRhythm Holdings, Inc.
 logo
iRhythm Holdings, Inc. IRTC
5M0.0%
Charles River Laboratories logo
Charles River LaboratoriesCRL
Summit Therapeutics logo
Summit TherapeuticsSMMT

Other financials

Income statement

See full
Revenue$2.4M-91.1%
Operating income-$47.1M-84.0%
Net income-$44.2M-95.1%
EPS (diluted)-$0.59-96.7%

Balance sheet

See full
Cash & equivalents$244.3M+221%
Total debt$17.0M-7.7%
Total equity$163.6M-49.7%
Total assets$478.2M+12.4%

Cash flow

See full
Operating cash flow-$45.7M-1,242%
CapEx$216.0K+1,250%
Free cash flow-$45.9M-1,242%

Valuation

See full
Market cap$1.76B+125%
Enterprise value$1.53B+112%
P/S21.6×+13.2×

Profitability

See full
Operating margin-140.4%+7.3pp
Net margin-126.3%+5.0pp
FCF margin-94.8%+15.5pp

Returns & leverage

See full
Return on equity-42%+29.2pp
Debt / equity0.1×0.0×
Current ratio10.8×+6.1×

Where this comes from

Reported directly by Zymeworks in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.

The official record: Zymeworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zymeworks's convertible preferred stock authorized shares.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Zymeworks's convertible preferred stock authorized shares?
Zymeworks (ZYME) reported convertible preferred stock authorized shares of 100M in Q1 2026.
How has Zymeworks's convertible preferred stock authorized shares changed year-over-year?
Zymeworks's convertible preferred stock authorized shares decreased by 0.0% year-over-year, from 100M to 100M.
What is the long-term trend for Zymeworks's convertible preferred stock authorized shares?
Over 3 years (2022 to 2025), Zymeworks's convertible preferred stock authorized shares has grown at a 0.0% compound annual growth rate (CAGR), from 100M to 100M.
What does convertible preferred stock authorized shares mean?
Maximum number of convertible preferred shares the company is authorized to issue under its corporate charter.